Evidence map›Paper›PMID 42196491›Full record

ReviewInternational journal of molecular sciences2026

Gold Nanorod-Radiopharmaceutical Conjugates for Nuclear Medicine Theranostics: A Methodological and Multiscale Perspective.

Ludovica Binelli, Andrea Attili, Iole Venditti, Chiara Battocchio, Valentina Dini, Maria Lucia Calcagni, Marco Ranaldi, Giovanna Iucci, Luca Tortora, Sveva Grande and 9 more

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Ludovica BinelliSciences Department, Roma Tre University, 00146 Rome, Italy.ORCID 0000-0001-7780-7898
Andrea AttiliIstituto Nazionale di Fisica Nucleare (INFN), Sezione di Roma3, 00146 Rome, Italy.ORCID 0000-0003-2765-4840
Iole VendittiSciences Department, Roma Tre University, 00146 Rome, Italy.ORCID 0000-0002-9306-573X
Chiara BattocchioSciences Department, Roma Tre University, 00146 Rome, Italy.ORCID 0000-0003-4590-0865
Valentina DiniNational Center of Artificial Intelligence and Innovative Technologies for Health, Istituto Superiore di Sanità, 00161 Rome, Italy.ORCID 0000-0003-4125-0084
Maria Lucia CalcagniIstituto Nazionale di Fisica Nucleare (INFN), Sezione di Roma3, 00146 Rome, Italy.
Marco RanaldiSciences Department, Roma Tre University, 00146 Rome, Italy.ORCID 0009-0005-6110-1942
Giovanna IucciSciences Department, Roma Tre University, 00146 Rome, Italy.ORCID 0000-0002-6478-3759
Luca TortoraSciences Department, Roma Tre University, 00146 Rome, Italy.ORCID 0000-0003-3053-2406
Sveva GrandeNational Center of Artificial Intelligence and Innovative Technologies for Health, Istituto Superiore di Sanità, 00161 Rome, Italy.ORCID 0000-0002-1925-7602
Alessandra PalmaNational Center of Artificial Intelligence and Innovative Technologies for Health, Istituto Superiore di Sanità, 00161 Rome, Italy.ORCID 0000-0002-8530-4913
Barbara De BerardisNational Center of Artificial Intelligence and Innovative Technologies for Health, Istituto Superiore di Sanità, 00161 Rome, Italy.ORCID 0000-0001-7857-9620
Maria Grazia AmmendoliaNational Center of Artificial Intelligence and Innovative Technologies for Health, Istituto Superiore di Sanità, 00161 Rome, Italy.ORCID 0000-0003-4121-3005
Teresa ScotognellaIstituto Nazionale di Fisica Nucleare (INFN), Sezione di Roma3, 00146 Rome, Italy.ORCID 0000-0002-2388-2961
Francesca CampanaroNuclear Medicine Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
Monica DettinDepartment of Industrial Engineering, University of Padova, 35131 Padova, Italy.ORCID 0000-0002-6823-3375
Lucrezia BianchiIstituto Nazionale di Fisica Nucleare (INFN), Sezione di Roma3, 00146 Rome, Italy.ORCID 0009-0008-6436-9823
Antonella RosiIndependent Researcher, 00161 Rome, Italy.
Andrea FabbriIstituto Nazionale di Fisica Nucleare (INFN), Sezione di Roma3, 00146 Rome, Italy.

Funding

Istituto Nazionale di Fisica Nucleare SEGNAR
6 · The paper itself

Abstract

The creation of innovative systems that are able to combine diagnosis and therapy is a crucial opportunity in nuclear medicine. Here, we propose a methodological and multiscale approach for the development of a theranostic platform based on AuNRs functionalized with radiopharmaceuticals. AuNRs offer a versatile and effective system due to their unique physicochemical properties and the possibility of surface functionalization with targeting molecules. Within this framework, key challenges include the functionalization of AuNRs to target the cell nucleus, the loading of AuNRs with radiopharmaceuticals, and the investigation of Auger electron emission from AuNRs under gamma irradiation. Multiscale modelling is employed to describe the behaviour of the system within the cellular environment and to predict potential radiobiological enhancement effects, including synergistic interactions between functionalized AuNRs and radiopharmaceutical agents such as

Indexed as

GoldNanotubesNuclear MedicineRadiopharmaceuticalsTheranostic NanomedicineAnimalsHumansGoldRadiopharmaceuticalsAuger electronsdrug delivery systemgold nanoparticlesMonte Carlo simulationsradiobiologytheranostic

Identifiers

PMID42196491
PMCPMC13206782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.